1. A novel approach to restore function of stroke or trauma related paralyzed limbs. (17th November 2017) Authors: Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 45:Number 8(2017) Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. (February 2015) Authors: Bian, Yuzhu; Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 43:Number 1(2015:Feb.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A polymer–lipid membrane artificial cell nanocarrier containing enzyme–oxygen biotherapeutic inhibits the growth of B16F10 melanoma in 3D culture and in a mouse model. Issue 1 (1st January 2021) Authors: Wang, Yun; Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 49:Issue 1(2021) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Issue 1 (4th December 2019) Authors: Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 47:Issue 1(2019) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hepatoprotective effects of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] on alcohol-damaged primary rat hepatocyte culture in vitro. (2nd January 2017) Authors: Jiang, Wenhua; Bian, Yuzhu; Wang, Zhenghui; Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 45:Number 1(2017) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats. (28th November 2012) Authors: Liu, Zun Chang; Chang, Thomas Ming Swi Other Names: Bunnell B. Academic Editor. Journal: Stem cells international Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. (3rd October 2018) Authors: Guo, Chen; Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 46:Number 7(2018) Page Start: 1349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Red blood cell replacement, or nanobiotherapeutics with enhanced red blood cell functions?. (June 2015) Authors: Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 43:Number 3(2015:Jun.) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO2 and replenish blood supply. Issue 1 (31st December 2022) Authors: Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 50:Issue 1(2022) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functions. (19th May 2017) Authors: Chang, Thomas Ming Swi Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 45:Number 4(2017) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗